Small-molecule therapyVeralox Therapeutics provides small-molecule therapy. It develops a therapy for immune-mediated blood disorders, beginning with heparin-induced thrombocytopenia (HIT). Veralox Therapeutics was founded in 2017 and is based in Frederick, Maryland.Veralox Therapeutics - Products, Competitors, Financials, Employ…www.cbinsights.com/company/veralox-therapeutics...